Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study

By Rogers S.L.   Doody R.S.   Pratt R.D.   Ieni J.R.  

European Neuropsychopharmacology, Vol. 10, Iss. 3, 2000-05 ,pp. : 195-203

Elsevier

Access to resources Recommend Favorite

Changes in Nursing Burden Following Memantine for Agitation and Aggression in Long-Term Care Residents with Moderate to Severe Alzheimer's Disease: An Open-Label Pilot Study

By Herrmann Nathan   Cappell Jaclyn  

CNS Drugs, Vol. 25, Iss. 5, 2011-05 ,pp. : 425-433

Adis International

Access to resources Recommend Favorite

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study

By Rogers S.L.   Friedhoff L.T.  

European Neuropsychopharmacology, Vol. 8, Iss. 1, 1998-02 ,pp. : 67-75

Elsevier

Access to resources Recommend Favorite

Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine

By Chrzanowski Wlodzimierz   Marcus Ronald   Torbeyns Anne   Nyilas Margaretta   McQuade Robert  

Psychopharmacology, Vol. 189, Iss. 2, 2006-12 ,pp. : 259-266

Springer Publishing Company

Access to resources Recommend Favorite

An Open-Label Long-Term Naturalistic Study of Mirtazapine Treatment for Depression in Cancer Patients

By Ersoy Mehmet A.   Noyan Aysin M.   Elbi Hayriye  

Clinical Drug Investigation, Vol. 28, Iss. 2, 2008-01 ,pp. : 113-120

Adis International

Access to resources Recommend Favorite